Can we afford the cure? Exploring drug costs, access, and outcomes
Watch: Learn more about the implications of rising drug prices on affordability and access in the health care system.
Sameer Awsare, MD, highlights Kaiser Permanente model in case for biosimilars market
Physician leader Sameer Awsare, MD, FACP, co-writes an article in Health Affairs encouraging competition in the biosimilar drugs market to help curb rising health care costs.
Sameer Awsare, MD, Addresses Rising Drug Prices
Sameer Awsare, MD, associate executive director of The Permanente Medical Group, spoke at last fall’s Southern California edition of the State of Reform Health Policy Conference, drawing attention to the growing problem of rising drug prices. The State of Reform…